{"id":1632,"date":"2014-12-18T11:31:14","date_gmt":"2014-12-18T02:31:14","guid":{"rendered":"http:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/?page_id=1632"},"modified":"2015-01-20T11:20:25","modified_gmt":"2015-01-20T02:20:25","slug":"2009%e4%bb%a5%e5%89%8d%e3%81%ae%e8%ab%96%e6%96%87","status":"publish","type":"page","link":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/researc\/2009%e4%bb%a5%e5%89%8d%e3%81%ae%e8%ab%96%e6%96%87\/","title":{"rendered":"2009"},"content":{"rendered":"

2009<\/h2>\n
    \n
  1. Ogawa K, Kawashima H, Kinuya S, Shiba K, Onoguchi M, Kimura H, Hashimoto K, Odani A, Saji H.
    \nPreparation and evaluation of\u00a0186\/188<\/sup>Re-labeled antibody (A7) for radioimmunotherapy with rhenium(I) tricarbonyl core as a chelate site
    \nAnn. Nucl. Med.<\/em>\u00a023<\/strong>\u00a0(10) 843-848 (2009)<\/li>\n
  2. Mukai E, Toyoda K, Kimura H, Kawashima H, Fujimoto H, Ueda M, Temma T, Hirao K, Nagakawa K, Saji H, Inagaki N.
    \nGLP-1 receptor antagonist as a potential probe for pancreatic \u03b2-cell imaging
    \nBiochem. Biophys. Res. Commun.<\/em>\u00a0389<\/strong>\u00a0(3) 523-526 (2009)<\/li>\n
  3. Kuge Y, Obokata N, Kimura H, Katada Y, Temma T, Sugimoto Y, Aita K, Seki K.-i, Tamaki N, Saji H.
    \nSynthesis and evaluation of a radioiodinated lumiracoxib derivative for the imaging of cyclooxygenase-2 expression
    \nNucl. Med. Biol.<\/em>\u00a036<\/strong>\u00a0(8) 869-876 (2009)<\/li>\n
  4. Ono M, Watanabe R, Kawashima H, Yan C, Kimura H, Watanabe H, Haratake M, Saji H, Nakayama M.
    \nFluoro-pegylated chalcones as positron emission tomography probes for in vivo imaging of \u03b2-amyloid plaques in Alzheimer’s disease
    \nJ. Med. Chem.<\/em>\u00a052<\/strong>\u00a0(20) 6394-6401 (2009)<\/li>\n
  5. Ono M, Hayashi S, Kimura H, Kawashima H, Nakayama M, Saji H.
    \nPush-pull benzothiazole derivatives as probes for detecting \u03b2-amyloid plaques in Alzheimer’s brains
    \nBioorg. Med. Chem.<\/em>\u00a017<\/strong>\u00a0(19) 7002-7007 (2009)<\/li>\n
  6. Watanabe H, Ono M, Ikeoka R, Haratake M, Saji H, Nakayama M.
    \nSynthesis and biological evaluation of radioiodinated 2,5-diphenyl-1,3,4-oxadiazoles for detecting \u03b2-amyloid plaques in the brain
    \nBioorg. Med. Chem.<\/em>\u00a017<\/strong>\u00a0(17) 6402-6406 (2009)<\/li>\n
  7. Temma T, Sano K, Kuge Y, Kamihashi J, Takai N, Ogawa Y, Saji H.
    \nDevelopment of a radiolabeled probe for detecting membrane type-1 matrix metalloproteinase on malignant tumors
    \nBiol. Pharm. Bull.<\/em>\u00a032<\/strong>\u00a0(7) 1272-1277 (2009)<\/li>\n
  8. Kudo T, Ueda M, Kuge Y, Mukai T, Tanaka S, Masutani M, Kiyono Y, Kizaka-Kondoh S, Hiraoka M, Saji H.
    \nImaging of HIF-1-active tumor hypoxia using a protein effectively delivered to and specifically stabilized in HIF-1-active tumor cells
    \nJ. Nucl. Med.<\/em>\u00a050<\/strong>\u00a0(6) 942-949 (2009)<\/li>\n
  9. Ono M, Watanabe R, Kawashima H, Kawai T, Watanabe H, Haratake M, Saji H, Nakayama M.
    \n18<\/sup>F-labeled flavones for in vivo imaging of \u03b2-amyloid plaques in Alzheimer’s brains
    \nBioorg. Med. Chem.<\/em>\u00a017<\/strong>\u00a0(5) 2069-2076 (2009)<\/li>\n
  10. Ogawa M. Tsukada H, Hatano K, Ouchi Y, Saji H, Magata Y.
    \nCentral in vivo nicotinic acetylcholine receptor imaging agents for positron emission tomography (PET) and single photon emission computed tomography (SPECT)
    \nBiol. Pharm. Bull.<\/em>\u00a032<\/strong>\u00a0(3) 337-340 (2009)<\/li>\n
  11. Ogawa K, Kawashima H, Shiba K, Washiyama K, Yoshimoto M, Kiyono Y, Ueda M, Mori H, Saji H.
    \nDevelopment of [90<\/sup>Y]DOTA-conjugated bisphosphonate for treatment of painful bone metastases
    \nNucl. Med. Biol.<\/em>\u00a036<\/strong>\u00a0(2) 129-135 (2009)<\/li>\n
  12. Maya Y, Ono M, Watanabe H, Haratake M, Saji H, Nakayama M.
    \nNovel radioiodinated aurones as probes for SPECT imaging of \u03b2-amyloid plaques in the brain
    \nBioconjugate Chem.<\/em>\u00a020<\/strong>\u00a0(1) 95-101 (2009)<\/li>\n
  13. Ogawa K, Mukai T, Kawai K, Takamura N, Hanaoka H, Hashimoto K, Shiba K, Mori H, Saji H.
    \nUsefulness of competitive inhibitors of protein binding for improving the pharmacokinetics of\u00a0186<\/sup>Re-MAG3-conjugated bisphosphonate (186<\/sup>Re-MAG3-HBP), an agent for treatment of painful bone metastases
    \nEur. J. Nucl. Med. Mol. Imaging<\/em>\u00a036<\/strong>\u00a0(1) 115-121 (2009)<\/li>\n<\/ol>\n

     <\/p>\n

    \u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

    2009 Ogawa K, Kawashima H, Kinuya S, Shiba K, Onoguchi M, Kimura H, Hashimoto K, Odani A, Saji H. Preparation […]<\/p>\n","protected":false},"author":14,"featured_media":0,"parent":363,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_crdt_document":"","footnotes":""},"class_list":["post-1632","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/pages\/1632","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/comments?post=1632"}],"version-history":[{"count":5,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/pages\/1632\/revisions"}],"predecessor-version":[{"id":1671,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/pages\/1632\/revisions\/1671"}],"up":[{"embeddable":true,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/pages\/363"}],"wp:attachment":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/media?parent=1632"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}